Back to Search
Start Over
Cardiovascular risk in women with polycystic ovary syndrome.
- Source :
-
Minerva endocrinologica [Minerva Endocrinol] 2007 Dec; Vol. 32 (4), pp. 263-73. - Publication Year :
- 2007
-
Abstract
- Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed.
- Subjects :
- Atherosclerosis etiology
Biomarkers blood
Body Weight
Cardiovascular Diseases blood
Cardiovascular Diseases prevention & control
Diabetes Mellitus, Type 2 complications
Exercise
Female
Humans
Hypoglycemic Agents therapeutic use
Metformin therapeutic use
Pioglitazone
Polycystic Ovary Syndrome blood
Polycystic Ovary Syndrome drug therapy
Polycystic Ovary Syndrome surgery
Risk Factors
Risk Reduction Behavior
Rosiglitazone
Thiazolidinediones therapeutic use
Vasodilator Agents therapeutic use
Weight Loss
Cardiovascular Diseases etiology
Polycystic Ovary Syndrome complications
Polycystic Ovary Syndrome therapy
Subjects
Details
- Language :
- English
- ISSN :
- 0391-1977
- Volume :
- 32
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Minerva endocrinologica
- Publication Type :
- Academic Journal
- Accession number :
- 18091663